Protein kinase C activity blocks neuropeptide Y-mediated inhibition of glutamate release and contributes to excitability of the hippocampus in status epilepticus

FASEB Journal

Volumn 21, Issue 3, 2007, Pages 671-681

  Silva, Ana P ^a,b   Lourenço, Joana ^b   Xapelli, Sara ^b   Ferreira, Raquel ^b   Kristiansen, Heidi ^c,d   Woldbye, David P D ^c,d   Oliveira, Catarina R ^a,b   Malva, João O ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Nerve terminal; Phosphorylation; Seizures; Y2 receptor

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR 1; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; KAINIC ACID; NEUROPEPTIDE Y; NEUROPEPTIDE Y2 RECEPTOR; POTASSIUM CHLORIDE; PROTEIN KINASE C; SERINE; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPILEPTIC STATE; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NEUROPEPTIDE Y; PROTEIN KINASE C; RATS; RATS, WISTAR; STATUS EPILEPTICUS;

RATTUS;

EID: 33847374757     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-6163com     Document Type: Article

References (66)

1. Wettstein, J. G., Earley, B., and Junien, J. L. (1995) Central nervous system pharmacology of neuropeptide Y. Pharmacol. Ther. 65, 397-414
2. Berglund, M. M., Hipskind, P. A., and Gehlert, D. R. (2003) Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp. Biol. Med. 228, 217-244
3. Silva, A. P., Xapelli, S., Grouzmann, E., and Cavadas, C. (2005) The putative neuroprotective role of neuropeptide Y in the central nervous system. Curr. Drug. Targets. CNS. Neurol. Disord. 4, 331-347
4. Wahlestedt, C., and Reis, D. J. (1993) Neuropeptide Y-related peptides and their receptors-are the receptors potential therapeutic drug targets? (Review) Ann. Rev. Pharmacol. Toxicol. 32, 309-352
5. Vezzani, A., Sperk, G., and Colmers, F. (1999) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22, 25-30
6. Colmers, W. F., and El Bahh, B. (2003) Neuropeptide Y and epilepsy. Epilepsy Curr. 3, 53-58
7. Woldbye, D. P., and Kokaia, M. (2004) Neuropeptide Y and seizures: effects of exogenously applied ligands. Neuropeptides 38, 253-260
8. Michel, M. C., Beck-Sickinger, A., Cox, H., Doods, H. N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T., and Westfall, T. (1998) International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50, 143-150
9. Parker, R. M. C., and Herzog, H. (1999) Regional distribution of Y-receptor subtype mRNA in rat brain. Eur. J. Neurosci. 11, 1431-1448
10. Wu, Y. F., and Li, S. B. (2005) Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity. Acta Pharmacol. Sin. 26, 63-68
11. Gobbi, M., Gariboldi, M., Piwko, C., Hoyer, D., Sperk, G., and Vezzani, A. (1998) Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J. Neurochem. 70, 1615-1622
12. El Bahh, B., Balosso, S., Hamilton, T., Herzog, H., Beck-Sickinger, A. G., Sperk, G., Gehlert, D. R., Vezzani, A., Colmers, W. F. (2005) The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y, and not Y5 receptors. Eur. J. Neurosci. 22, 1417-1430
13. Woldbye, D. P., Nanobashvili, A., Sorensen, A. T., Husum, H., Bolwig, T. G., Sorensen, G., Ernfors, P., and Kokaia, M. (2005) Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors. Neurobiol. Dis. 20, 760-772
14. Erickson, J. C., Clegg, K. E., and Palmiter, R. D. (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381, 415-421
15. Baraban, S. C., Hollopeter, G., Erickson, J. C., Schwartzkroin, P. A., and Palmiter, R. D. (1997) Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17, 8927-8936
16. Vezzani, A., Michalkiewicz, M., Michalkiewicz, T., Moneta, D., Ravizza, T., Richichi, C., Aliprandi, M., Mulé, F., Gobbi, M., Schwarzzer, C., and Sperk, G. (2002) Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110, 237-243
17. Richichi, C., Lin, E. J., Stefanin, D., Colella, D., Ravizza, T., Grignaschi, G., Veglianese, P., Sperk, G., During, M. J., and Vezzani, A. (2004) Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J. Neurosci. 24, 3051-3059
18. 2 receptor. Br. J. Pharmacol. 102, 41-44
19. Bleakman, D., Harrison, N. L., Colmers, W. F., and Miller, R. J. (1992) Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat. Br. J. Pharmacol. 107, 334-340
20. Greber, S., Schwarze, C., and Sperk, G. (1994) Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113, 737-740
21. Silva, A. P., Xapelli, S., Pinheiro, P. S., Ferreira, R., Lourenço, J., Cristovão, A., Grouzmann, E., Cavadas, C., Oliveira, C. R., and Malva, J. O. (2005) Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats. J. Neurochem. 93, 163-170
22. Klapstein, G. J., and Colmers, W. F. (1997) Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol. 78, 1651-1661
23. Woldbye, D. P. D., Larsen, P. J., Mikkelsen, J. D., Klemp, K., Madsen, T. M., and Bolwig, T. G. (1997) Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nature Med. 3, 761-764
24. Cambray-Deakin, M. A., Adu, J., and Burgoyne, R. D. (1990) Neuritogenesis in cerebellar granule cells in vitro: a role for protein kinase C. Brain Res. Dev. Brain Res. 53, 40-46
25. Campenot, R. B., Draker, D. D., and Senger, D. L. (1994) Evidence that protein kinase C activities involved in regulating neurite growth are localized to distal neurites. J. Neurochem. 63, 868-878
26. Parrow, V., Fagerstrom, S., Meyerson, G., Nanberg, E., and Pahlman, S. (1995) Protein kinase C-alpha and -epsilon are enriched in growth cones of differentiating SH-SY5Y human neuroblastoma cells. J. Neurosci. Res. 41, 782-791
27. Felipo, V., Minana, M. D., and Grisolia, S. (1993) Inhibitors of protein kinase C prevent the toxicity of glutamate in primary neuronal cultures. Brain Res. 604, 192-196
28. Robinson, P. J. (1992) The role of protein kinase C and its neuronal substrates dephosphin, B-50, and MARCKS in neurotransmitter release. Mol. Neurobiol. 5, 87-130
29. Wang, S. J. (2006) Facilitatory effect of aspirin on glutamate release from rat hippocampal nerve terminals: involvement of protein kinase C pathway. Neurochem. Int. 48, 181-190
30. Redman, R. S., Searl, T. J., Hirsh, J. K., Silinsky, E. M. (1997) Opposing effects of phorbol esters on transmitter release and calcium currents at frog motor nerve endings. J. Physiol. 15, 41-48
31. Hoffman, D. A., and Johnston, D. (1998) Downregulation of transient K+ channels in dendrites of hippocampal CA1 pyramidal neurons by activation of PKA and PKC. J. Neurosci. 15, 3521-3528
32. Chow, K. B., Jones, R. L., and Wise, H. (2003) Protein kinase A-dependent coupling of mouse prostacyclin receptors to Gi is cell-type dependent. Eur. J. Pharmacol. 474, 7-13
33. Bijak, M. (1999) Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes. Neurosci. Lett. 268, 115-118
34. Marsh, D. J., Baraban, S. C., Hollopeter, G., and Palmiter, R. D. (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc. Natl. Acad. Sci. U. S. A. 96, 13518-13523
35. Sperk, G., Lassmann, H., Baran, H., Seitelberger, F., and Hornykiewicz, O. (1985) Kainic acid-induced seizures: doserelationship of behavioural, neurochemical and histopathological changes. Brain Res. 338, 289-295
36. McMahon, T. H., Foran, P., Dolly, J. O., Verhage, M., Wiegant, V. M., and Nicholls, D. G. (1992) Tetanus toxin and botulinum toxins type A and B inhibit glutamate, γ-aminobutyric acid, aspartate, and Met-en-kephalin release from synaptosomes. J. Biol. Chem. 267, 21338-21343
37. Malva, J. O., Carvalho, A. P., and Carvalho, C. M. (1996) Domoic acid induces the release of glutamate in the rat hippocampal CA3 sub-region. NeuroReport 7, 1330-1344
38. Silva, A. P., Carvalho, A. P., Carvalho, C. M., and Malva, J. O. (2001) Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. J. Neurochem. 79, 286-296
39. Whittaker, V. P. (1984) The synaptosome. In Handbook of Neurochemistry (Lajtha, A., eds) Vol. 7, pp. 1-39, Plenum Press, New York
40. Layne, E. (1957) Spectophotometric and turbidimetric methods for measuring proteins. In Methods in Enzimology (Colowick, S. P., and Kaplan, N. O., eds) Vol. 3, pp. 447-451, Academic, New York
41. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klen, D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85
42. Nicholls, D. G., Sihra, T. S., and Sanchez-Prieto, J. (1987) Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J. Neurochem. 49, 50-57
43. Pinheiro, P. S., Rodrigues, R. J., Rebola, N., Xapelli, S., Oliveira, C. R., and Malva, J. O. (2005) Presynaptic kainate receptors are localized close to release sites in rat hippocampal synapses. Neurochem. Int. 47, 309-316
44. 35S]thio]-triphosphate binding. Proc. Natl. Acad. Sci. U. S. A. 92, 7242-7246
45. Silva, A. P., Carvalho, A. P., Carvalho, C. M., and Malva, J. O. (2003) Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 42, 282-292
46. Parfitt, K. D., and Madison, D. V. (1993) Phorbol esters enhance synaptic transmission by a presynaptic, calcium-dependent mechanism in rat hippocampus. J. Physiol. 471, 245-268
47. 3H]5-hydroxytryptamine in the spinal cord of the rat: the role of L-type voltage-dependent calcium channels. Neuropharmacology 31, 1101-1109
48. Herrero, L, Miras-Portugal, M. T., and Sánchez-Prieto, J. (1992) Activation of protein kinase C by phorbol esters and arachidonic acid required for the optimal potentiation of glutamate exocytosis. J. Neurochem. 59, 1574-1577
49. Coffey, E. T., Sihra, T. S., and Nicholls, D. G. (1993) Protein kinase C and the regulation of glutamate exocytosis from cerebrocortical synaptosomes. J. Biol. Chem. 268, 21060-21065
50. Guglielmetti, F., Rattray, M., Baldessari, S., Butelli, E., Samanin, R., and Bendotti, C. (1997) Selective up-regulation of protein kinase C in granule cells after kainic acid-induced seizures in rat. Brain Res. Mol. Brain Res. 49, 188-196
51. McNamara, R. K., and Lenox, R. H. (2000) Differential regulation of primary protein kinase C substrate (MARCKS, MLP, GAP 43, RC3) mRNAs in the hippocampus during kainic acidinduced seizures and synaptic reorganization. J. Neurosci. Res. 62, 416-426
52. Tan, S. E., Wenthold, R. J., and Soderling, T. R. (1994) Phosphorylation of AMPA-type glutamate receptors by calcium/calmodulin-dependent protein kinase II and protein kinase C in cultured hippocampal neurons. J. Neurosci. 14, 1123-1129
53. Blackstone, C., Murphy, T. H., Moss, S. J., Baraban, J. M., and Huganir, R. L. (1994) Cyclic AMP and synaptic activity-dependent phosphorylation of AMPA-preferring glutamate receptors. J. Neurosci. 14, 7585-7593
54. Roche, K. W., O'Brien, R. J., Mammen, A. L., Bernhardt, J., Huganir, R. L. (1996) Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16, 1179-1188
55. Dumont, Y., Cadieux, A., Doods, H., Pheng, L. H., Abounader, R., Hamel, E., Jacques, D., Regoli, D., and Quirion, R. (2000) BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br. J. Pharmacol. 129, 1075-1088
56. Toth, P. T., Bindokas, V. P., Bleakman, D., Colmers, W. F., and Miller, R. J. (1993) Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals. Nature 364, 635-639
57. Klapstein, G. J., and Colmers, W. F. (1992) 4-Aminopyridine and low Ca2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro. Br. J. Pharmacol. 105, 470-474
58. Rhim, H., Kinney, G. A., Emmerson, P. J., and Miller, R. J. (1997) Regulation of neurotransmission in the arcuate nucleus of the rat by different neuropeptide Y receptors. J. Neurosci. 17, 2980-2989
59. Whittaker, E., Vereker, E., and Lynch, M. A. (1999) Neuropeptide Y inhibits glutamate release and long-term potentiation in rat dentate gyrus. Brain Res. 827, 229-233
60. Sanchez-Prieto, J., Budd, D. C., Herrero, I., Vazquez, E., Nicholls, D. G. (1996) Presynaptic receptors and the control of glutamate exocytosis. Trends Neurosci. 19, 235-239
61. Hori, T., Takai, Y., and Takahashi, T. (1999) Presynaptic mechanism for phorbol ester-induced synaptic potentiation. J. Neurosci. 19, 7262-7267
62. Tang, F. R., Lee, W. L., Gao, H., Chen, Y., Loh, Y. T., and Chia, S. C. (2004) Expression of different isoforms of protein kinase C in the rat hippocampus after pilocarpine-induced status epilepticus with special reference to CA1 area and the dentate gyrus. Hippocampus 14, 87-98
63. Hussain, R. J., and Carpenter, D. O. (2003) The effects of protein kinase C activity on synaptic transmission in two areas of rat hippocampus. Brain Res. 990, 28-37
64. Swartz, K. J., Merritt, A., Bean, B. P., Lovinger, D. M. (1993) Protein kinase C modulates glutamate receptor inhibition of Ca2+ channels and synaptic transmission. Nature 361, 165-168
65. Lan, J. Y., Skeberdis, V. A., Jover, T., Grooms, S. Y., Lin, Y., Araneda, R. C., Zheng, X., Bennett, M. V., and Zukin, R. S. (2001) Protein kinase C modulates NMDA receptor trafficking and gating. Nat. Neurosci. 4, 382-390
66. Garcia-Sainz, J. A., Vazquez-Cuevas, F. G., and Romero-Avila, M. T. (2001) Phosphorylation and desensitization of alpha1d-adrenergic receptors. Biochem. J. 353, 603-610